Mazdutide is a dual GLP-1/glucagon agonist developed by Innovent Biologics, primarily studied in Chinese populations, showing weight loss of 14-18% in clinical trials
Poor glycemic control has also been linked to the development of hearing impairment in prior literature [23]
"I do think we're all going to have to be a little bit patient, because there is probably going to be a bit of a strain on clinics and pharmacies for the next couple of months as people very excitedly start these medications," Francavilla said
Since SoWell Electrolytes is specifically designed for GLP-1 users, we enhanced it with vitamin B6 to ward off nausea as much as possible
3 Challenges in clinical translation and industrial feasibility Currently, while some simple oral liposomal formulations (such as nutritional supplements, vitamins, and liposomal iron) are commercially available and being evaluated in clinical settings, the clinical translation of advanced surface-modified liposomes for prescription drugs remains largely in the preclinical or early clinical trial stages (Rangaraj et al., 2025)
